Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (391-400 of 741) with videos related to

Pageof 75
Sort By:
Archives of Neurology|May 11, 2011
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathologyAnne M Fagan, Leslie M Shaw, Chengjie Xiong, et al.
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other TauopathiesT West, Y Hu, P B Verghese, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2012
Bidirectional relationship between functional connectivity and amyloid-β deposition in mouse brainAdam W Bero, Adam Q Bauer, Floy R Stewart, et al.
Annals of Neurology|March 17, 2007
Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutationJohn S K Kauwe, Sarah Jacquart, Sumi Chakraverty, et al.
Acta Neuropathologica|January 13, 2016
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation statusLaura Piccio, Yuetiva Deming, Jorge L Del-Águila, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 2, 2021
Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum ExposureXianwei Chen, Guoqiang Sun, E Tian, et al.
Journal of Neuroimmunology|May 6, 2014
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosisSoomin Shin, Katharine A Walz, Angela S Archambault, et al.
Neurobiology of Disease|February 15, 2000
BDNF blocks caspase-3 activation in neonatal hypoxia-ischemiaB H Han, A D'Costa, S A Back, et al.
Science (New York, N.Y.)|September 26, 2009
Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycleJae-Eun Kang, Miranda M Lim, Randall J Bateman, et al.
Molecular Neurodegeneration|April 19, 2015
Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse modelFan Liao, Hong Jiang, Subhashini Srivatsan, et al.
Pageof 75

Showing results (391-400 of 741) with videos related to

Sort By:
Pageof 75
Archives of Neurology|May 11, 2011
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathologyAnne M Fagan, Leslie M Shaw, Chengjie Xiong, et al.
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other TauopathiesT West, Y Hu, P B Verghese, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2012
Bidirectional relationship between functional connectivity and amyloid-β deposition in mouse brainAdam W Bero, Adam Q Bauer, Floy R Stewart, et al.
Annals of Neurology|March 17, 2007
Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutationJohn S K Kauwe, Sarah Jacquart, Sumi Chakraverty, et al.
Acta Neuropathologica|January 13, 2016
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation statusLaura Piccio, Yuetiva Deming, Jorge L Del-Águila, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 2, 2021
Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum ExposureXianwei Chen, Guoqiang Sun, E Tian, et al.
Journal of Neuroimmunology|May 6, 2014
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosisSoomin Shin, Katharine A Walz, Angela S Archambault, et al.
Neurobiology of Disease|February 15, 2000
BDNF blocks caspase-3 activation in neonatal hypoxia-ischemiaB H Han, A D'Costa, S A Back, et al.
Science (New York, N.Y.)|September 26, 2009
Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycleJae-Eun Kang, Miranda M Lim, Randall J Bateman, et al.
Molecular Neurodegeneration|April 19, 2015
Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse modelFan Liao, Hong Jiang, Subhashini Srivatsan, et al.
Pageof 75